Arif N. Ali

NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma

Christina Tsien, Stephanie L. Pugh, Adam P. Dicker et al. · Journal of Clinical Oncology · 2022 · 199 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Radiation-induced tumor neoantigens: imaging and therapeutic implications.

Christopher D. Corso, Arif N. Ali, Roberto Díaz · PubMed · 2011 · 57 citations

Medicine, Cancer Biology, Oncology +17

Machine-learning based classification of glioblastoma using delta-radiomic features derived from dynamic susceptibility contrast enhanced magnetic resonance images

Jiwoong Jeong, Liya Wang, Bing Ji et al. · Quantitative Imaging in Medicine and Surgery · 2019 · 57 citations · Full text

Medicine, Oncology, Radiology +17

Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (NRG Oncology/RTOG 1205): Initial Outcomes and RT Plan Quality Report

Christina Tsien, S. Pugh, Adam P. Dicker et al. · International Journal of Radiation Oncology*Biology*Physics · 2019 · 50 citations

Medicine, Oncology, Radiation Oncology +17

Bevacizumab‐induced hypertension is a predictive marker for improved outcomes in patients with recurrent glioblastoma treated with bevacizumab

Jim Zhong, Arif N. Ali, Alfredo Voloschin et al. · Cancer · 2014 · 44 citations · Full text

Medicine, Oncology, Pharmacotherapy +15